Squarepoint’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Squarepoint's ATEX Position: Q2 2026 in Review
Squarepoint sold out of Anterix (ATEX) in Q2 2026, closing a stake of 59,736 shares — an estimated $2.28M sold.
Squarepoint first reported a position in ATEX in Q1 2019 and held it in 19 quarters. The position peaked at $2.28M in Q1 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Squarepoint reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
- Squarepoint sold 59,736 Anterix shares in Q2 2026, an estimated $2.28M.
- Squarepoint first reported a position in Anterix in Q1 2019 and held it in 19 quarters.
- Squarepoint's Anterix position peaked at $2.28M in Q1 2026.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.